Onsite Updates and Insights from Nexus 2016
The Academy of Managed Care Pharmacy will host the Nexus 2016 conference, October 3-6, 2016, in National Harbor, Md. AMCP will be onsite, providing daily coverage for its members. Look for the Daily Reports in your inbox each morning starting October 4.
As 2016 nears its end, Nexus 2016 will provide essential updates and insights to give managed care professionals the foundation for success in 2017. The rapidly evolving health care landscape will be a key focus for presenters.
“In the new health care world that increasingly values access, affordability, and improved outcomes, your knowledge and expertise has never been more relevant,” says Susan A. Cantrell, RPh, CAE, Chief Executive Officer of AMCP. “In this time of amazing innovation, a scientific, evidenced-based approach has never been more important. Yes, indeed, you’re the right people at the right place at the right time.”
Toward that end, the meeting will highlight areas such as disease states and how those therapies impact managed are; the current and future changes that can be expected from legislators and regulators; specialty pharmacy and the challenges of managing this space; and the use of research in managed care, turning data and trends into effective strategy.
Specifically, AMCP will provide its members with coverage on:
- Behavioral Economics—What does it all mean?
- Predictive Analytics: Application and Risk Management
- Emerging Lessons from Oncology Treatment Decision-making Programs
- Expanding Medication Therapy Management Beyond Medicare Part D Patients
- Bracing for Impact: Preparing for the 2018 Specialty Drug Spend
- And more.
Meta-analysis is a widely used strategy in comparative effectiveness research. Like any research tool, it offers valuable insights but is not without potential limitations, especially when applying results to patient care, said presenter Amy Heck Sheehan, PharmD, Associate Professor of Pharmacy Practice, Purdue University Indianapolis, IN. And while members of the health care industry often […]Read More
A number of high-impact specialty drugs are slated for approval over next two years, including the potential first FDA-approved targeted treatments for NASH and atopic dermatitis. “Specialty pipeline agents may offer important therapeutic, safety advantages,” said presenter Nicole Trask, PharmD, Clinical Consultant Pharmacist, UMass Medical School Clinical Pharmacy Services, Shrewsbury, MA. In evaluating these advantages, […]Read More
Before a new drug is officially launched in the market, the general public and health care payers can only estimate what the costs will be. “The media often report pre-launch estimates of the impact new drugs are expected to have on health care costs,” said presenter Michael Broder, MD, Partnership for Health Analytic Research, Beverly […]Read More
The role of pharmacists in patients’ understanding and acceptance of medication treatment pathways is important and “critical for effective management,” according to presenter Svetlana Korchevsky, PharmD, Senior Clinical Pharmacy Manager, Montefiore Medical Center, “critical for effective management.” In her presentation, Korchevsky and colleagues studied the pharmacist role in the telephonic management of oral anticoagulation (OAC) therapy within Montefiore […]Read More
Efforts to improve quality of care while lowering health care and pharmacy costs are being made across the board, and U.S. states are no exception. This effort “has spurred experimentation with medication therapy management (MTM) programs to optimize medication regimens and population health management, improve medication adherence, and manage medication costs,” said Marie Smith, PharmD, […]Read More